Abstract:A bstract Among virtual screening methods that have been developed to facilitate the drug discovery process, chemogenomics presents the particularity to tackle the question of predicting ligands for proteins, at at scales both in the protein and chemical spaces. Therefore, in addition to to predict drug candidates for a given therapeutic protein target, like more classical ligand-based or receptor-based methods do, chemogenomics can also predict off-targets at the proteome level, and therefore, identify potential side-effects or drug repositioning opportunities. In this study, we study and compare machine-learning and deep learning approaches for chemogenomics, that are applicable to screen large sets of compounds against large sets of druggable proteins. State-of-the-art drug chemogenomics methods rely on expert-based chemical and protein descriptors or similarity measures. The recent development of deep learning approaches enabled to design algorithms that learn numerical abstract representations of molecular graphs and protein sequences in an end-to-end fashion, i.e., so that the learnt features optimise the objective function of the drug-target interaction prediction task. In this paper, we address drug-target interaction prediction at the druggable proteome-level, with what we define as the chemogenomic neuron network. This network consists of a feed-forward neuron network taking as input the combination of molecular and protein representations learnt by molecular graph and protein sequence encoders. We first propose a standard formulation of this chemogenomic neuron network. Then, we compare the performances of the standard chemogenomic network to reference deep learning or shallow (machine-learning without deep learning) methods. In particular, we show that such a representation learning approach is competitive with state-of-the-art chemogenomics with shallow methods, but not ultimately superior. We evaluate the most promising neuron network architectures and data augmentation techniques, such as multi-view and transfer learning, to improve the prediction performance of the chemogenomic network. Our results shed new insights on the design of chemogenomics approaches based on representation learning algorithms. Most importantly, we conclude from our observations that a promising research direction is to integrate heterogeneous sources of data such as various bioactivity datasets, or independently, multiple molecule and protein attribute views, instead of focusing on sophisticated, yet intuitively relevant, encoder’s neuron network architecture.

Deep Learning-Based Modeling of Drug–Target Interaction Prediction Incorporating Binding Site Information of Proteins

Evaluation of deep and shallow learning methods in chemogenomics for the prediction of drugs specificity

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

DeepGS: Deep Representation Learning of Graphs and Sequences for Drug-Target Binding Affinity Prediction

How to approach machine learning-based prediction of drug/compound–target interactions

Evaluation of network architecture and data augmentation methods for deep learning in chemogenomics

Binding Affinity Prediction with 3D Machine Learning: Training Data and Challenging External Testing

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

519. DeepLPI: A Novel Drug Repurposing Model based on Ligand-Protein Interaction Using Deep Learning

Enhancing Drug-Target Binding Affinity Prediction through Deep Learning and Protein Secondary Structure Integration

Deep-Learning-Based Drug-Target Interaction Prediction.

Estimating protein–ligand interactions with geometric deep learning and mixture density models

Deep learning integration of molecular and interactome data for protein–compound interaction prediction

Deep generative model for drug design from protein target sequence

Drug - Target Interaction Prediction with a Deep-Learning-based Model.

DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences

De Novo Structure-Based Drug Design Using Deep Learning

Development and evaluation of a deep learning model for protein-ligand binding affinity prediction

On Machine Learning Approaches for Protein-Ligand Binding Affinity Prediction

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

Machine Learning for Sequence and Structure-Based Protein–Ligand Interaction Prediction